Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial
Status:
Recruiting
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate the effect of the hemostatic matrix with fibrinogen and thrombin
(TachoSil®) on vena cava inferior anastomoses during liver transplantation from a deceased
donor.
The research comprises two groups: an experimental cohort with patients receiving a
hemostatic matrix of fibrinogen and thrombin on the anastomotic line of the inferior vena
cava, and a control cohort utilizing hemostasis without matrix sealent. The study involves a
total of 170 participants, evenly distributed with 85 patients in each group.